BioRestorative: Prelim Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

  Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial —

— Company to host webcasted conference call today at 8:30am EST —

BioRestorative management will host a webcasted conference call with an associated slide presentation today, February 5, at 8:30AM EST. To join the conference call via phone and participate in the live Q&A session, please dial 888-506-0062 (United States) or 973-528-0011 (International), participant access code 234972. The live webcast and audio archive of the presentation may be accessed on the investor section of the BioRestorative website at https://www.biorestorative.com/investor-relations/. An archived replay will be available for approximately 90 days following the event.

https://www.globenewswire.com/news-release/2024/02/05/2823422/0/en/BioRestorative-Therapies-Presents-Preliminary-Clinical-Data-from-Phase-2-Study-of-BRTX-100-in-Chronic-Lumbar-Disc-Disease.html